New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

Ralf Kuriyel Biography and Net Worth

VP of Repligen

Ralf Kuriyel joined Repligen in October 2016 as the Senior Vice President, Research and Development where he oversees the Company’s R&D efforts. Mr. Kuriyel was previously Vice President of Applications for the single-use business unit within the Life Sciences division of Pall Corporation, whose acquisition by Danaher Corporation was completed in August 2015. At Pall, Mr. Kuriyel served as Vice President of R&D, Field Applications and Process Development Services from November 2014 to October 2016. In addition, Mr. Kuriyel served as Vice President, Applications R&D at Pall from November 2011 to November 2014. Mr. Kuriyel received a B.S. and an M.S. in Chemical Engineering from Rensselaer Polytechnic Institute and has completed his coursework for the Tufts University Ph.D. program in Chemical Engineering. He is an inventor of multiple patents and has co-authored over 30 scientific publications on bioprocessing, including separations technologies, membrane separations methods, protein processing and enhanced microfiltration techniques.

What is Ralf Kuriyel's net worth?: The estimated net worth of Ralf Kuriyel is at least $3.81 million as of March 11th, 2024. Mr. Kuriyel owns 24,260 shares of Repligen stock worth more than $3,810,276 as of April 19th. This net worth estimate does not reflect any other investments that Mr. Kuriyel may own. Additionally, Mr. Kuriyel receives a salary of $401,740.00 as VP at Repligen. Learn More about Ralf Kuriyel's net worth.
How old is Ralf Kuriyel?: Mr. Kuriyel is currently 66 years old. There are 5 older executives and no younger executives at Repligen. Learn More on Ralf Kuriyel's age.
What is Ralf Kuriyel's salary?: As the VP of Repligen Co., Mr. Kuriyel earns $401,740.00 per year. There are 3 executives that earn more than Mr. Kuriyel. The highest earning executive at Repligen is Mr. Olivier Loeillot, President & Chief Commercial Officer, who commands a salary of $1,490,000.00 per year. Learn More on Ralf Kuriyel's salary.
How do I contact Ralf Kuriyel?: The corporate mailing address for Mr. Kuriyel and other Repligen executives is 41 SEYON STREET BUILDING 1 SUITE 100, WALTHAM MA, 02453. Repligen can also be reached via phone at (781) 250-0111 and via email at [email protected]. Learn More on Ralf Kuriyel's contact information.
Has Ralf Kuriyel been buying or selling shares of Repligen?: Ralf Kuriyel has not been actively trading shares of Repligen during the last ninety days. Most recently, Ralf Kuriyel sold 3,517 shares of the business's stock in a transaction on Monday, March 11th. The shares were sold at an average price of $193.73, for a transaction totalling $681,348.41. Following the completion of the sale, the vice president now directly owns 24,260 shares of the company's stock, valued at $4,699,889.80. Learn More on Ralf Kuriyel's trading history.
Who are Repligen's active insiders?: Repligen's insider roster includes Nicolas Barthelemy (Director), James Bylund (SVP), Karen Dawes (Director), Carrie Eglinton Manner (Director), Christine Gebski (Insider), Anthony Hunt (CEO), Ralf Kuriyel (VP), Martin Madaus (Director), Thomas Ryan, Jr. (Director), and Jon Snodgres (CFO). Learn More on Repligen's active insiders.
Are insiders buying or selling shares of Repligen?: In the last year, Repligen insiders bought shares 2 times. They purchased a total of 1,000 shares worth more than $158,665.00. In the last year, insiders at the biotechnology company sold shares 6 times. They sold a total of 30,235 shares worth more than $5,742,533.77. The most recent insider tranaction occured on March, 11th when VP Ralf Kuriyel sold 3,517 shares worth more than $681,348.41. Insiders at Repligen own 1.2% of the company. Learn More about insider trades at Repligen.
Information on this page was last updated on 3/11/2024.

Ralf Kuriyel Insider Trading History at Repligen

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/11/2024	Sell	3,517	$193.73	$681,348.41	24,260
8/11/2022	Sell	4,840	$254.32	$1,230,908.80	19,270
8/30/2021	Sell	4,001	$282.13	$1,128,802.13
6/10/2021	Sell	6,802	$189.19	$1,286,870.38	27,112
5/14/2021	Sell	710	$172.29	$122,325.90	24,555
3/10/2021	Sell	8,000	$190.44	$1,523,520.00	27,265
3/4/2021	Sell	2,075	$192.00	$398,400.00	26,940
12/16/2020	Sell	435	$186.18	$80,988.30	25,654
8/6/2020	Sell	5,000	$153.79	$768,950.00	31,089
5/15/2020	Sell	435	$140.69	$61,200.15	26,089
5/13/2020	Sell	8,000	$127.80	$1,022,400.00	32,524
3/3/2020	Sell	450	$88.35	$39,757.50	29,079
2/26/2020	Sell	195	$86.60	$16,887.00	26,313
3/5/2019	Sell	2,240	$58.53	$131,107.20	21,043
2/28/2019	Sell	185	$59.16	$10,944.60	16,528
12/18/2018	Sell	311	$54.44	$16,930.84	12,294

Ralf Kuriyel Buying and Selling Activity at Repligen

Repligen Company Overview

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $157.06

$152.19

$159.35

50 Day Range

MA: $189.09

$157.06

$208.42

2 Week Range

Now: $157.06

$110.45

$211.13

Volume

751,337 shs

Average Volume

422,365 shs

Market Capitalization

$8.77 billion

P/E Ratio

218.14

Dividend Yield

N/A

Beta

1.02

New crypto project uncovers 2,050% in 65 days

From InvestorPlace | Ad

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

Ralf Kuriyel Biography and Net Worth

What is Ralf Kuriyel's net worth?

How old is Ralf Kuriyel?

What is Ralf Kuriyel's salary?

How do I contact Ralf Kuriyel?

Has Ralf Kuriyel been buying or selling shares of Repligen?

Who are Repligen's active insiders?

Are insiders buying or selling shares of Repligen?